Rituximab in combination with CHOP or fludarabine in low-grade lymphoma-Reference-Cited by-同舟云学术

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma

Published:2002-02 Issue:1 Volume:29 Page:36-40
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Czuczman Myron S,Fallon Alexandra,Mohr Alice,Stewart Carleton,Bernstein Zale P,McCarthy Philip,Skipper Marion,Brown Karen,Miller Kena,Wentling Diane,Klippenstein Donald,Loud Peter,Rock Mike K,Benyunes Mark,Grillo-López Antonio J,Bernstein Steven H

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference6 articles.

1. Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma;Grillo-López;Semin Oncol,1999

2. Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs;Demidem;Cancer Biother Radiopharm,1997

3. Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy;Czuczman;J Clin Oncol,1999

4. Phase II study of rituximab in combination with fludarabine in patients (pts) with low-grade or follicular B-cell lymphoma;Czuczman;Blood,2000

5. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: A multicenter study by the Group d-Etude des Lymphomes de l'Adulte;Solal-Celigny;J Clin Oncol,1996

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constant rate thermal analysis study of a trihydrate calcium atorvastatin and effect of grinding on its thermal stability;Journal of Thermal Analysis and Calorimetry;2023-09-23

2. An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies;Methods;2019-02

3. The Modified Vaccination Technique;Vaccines;2018-12-21

4. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method;International Immunopharmacology;2017-02

5. Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells;Oncotarget;2016-12-31